Avid Bioservices Inc (CDMO)

[JJ1223]

It remains disappointing that Steve King refuses to communicate with current and potential investors. With April approaching, it is obvious as to his intent. To read about upcoming events on the IHub message board speaks volumes on leadership. Curious as to where you got the information cj! Send it to SK, I did.

Known Upcoming Events

Jan24-26/Avid/Table#22: WCBP’17: 21st Symposium on Interface of Reg. & Analytical Sciences, WashDC http://www.casss.org/page/WCBP1700 (Theme: “Convergence & Harmonization”)

Jan17-20: Phacilitate's Immunotherapy World Conf., Miami http://www.immunotherapyforum.com
...Jan18 12:25-12:40pm: Dr. Jeff Hutchins (VP/PreClinRes), “Combination Immunotherapies - Opening the Gate: Increasing Tumor Infiltrating Activated T-Cells to Optimize & Expand the Benefits of Immune Checkpoint Therapies”

Feb6-7: GTCbio’s Immunotherapeutics & Immunomonitoring Conf., SanDiego https://www.gtcbio.com/conferences/immunotherapeutics-immunomonitoring-overview
...AGENDA: http://tinyurl.com/gmrlupq
...Feb7 2:05pm: Dr. Bruce Freimark(Res.Dir./Preclin.Oncology), “Blockade of PS Enhances the Anti-Tumor Activity of Immune Checkpoint Inhibitors by Induction of Adaptive Immune Responses Mechanism”

Feb20-22: CHI’s 5th Translational Models in Oncology & I-O, SanFran http://www.triconference.com/Pre-Clinical-Oncology-Models
...Dr. Bruce Freimark(Dir.Res/Preclin.Oncology), “Blockade of PS-Mediated Tumor Immune Suppression to Enhance Immune Checkpoint Therapies”

~Mar8: FY'17Q3 (qe 1-31-17) Financials & Conf. Call - http://ir.peregrineinc.com/events.cfm

??Apr1-5: AACR 2017, WashDC http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=105

Apr10-12: Immune Profiling World Congress 2017, WashDC (part of “World Vaccine Congress 2017”) http://tinyurl.com/zlr5cyj
...4-11-17 12:10pm: Dr. Jeff Hutchins(VP/PreClinRes.), “Increasing the Benefits of Immune Checkpoint Therapies Thru Increased Tumor Infiltrating Activated T-Cells”

??Jun2-6: ASCO 2017, Chicago https://am.asco.org

June12-17: CHI’s 2nd Annual Immunotherapy & Combinations Conf., Boston http://www.worldpreclinicalcongress.com/Cancer-Immunotherapy-Combinations
...Dr. Jeff Hutchins(VP/PreClinRes.): “Expansion & Activation of T-Cells via the Targeting of the Immunosuppressive Ligand PS: Combination Strategy with Conventional, Targeted, and Checkpoint Inhibitor Therapy”

~Jul13: FY'17Q4 (fye 4-30-17) Financials & Conf. Call - http://ir.peregrineinc.com/events.cfm